Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

March 14, 2024 |  

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences sectors.

Dive into essential insights with our ‘Top 10 Most Important Advisor Questions’ series. This quick video covers Tip #9, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences sectors.

See the full video here: https://www.youtube.com/watch?v=HFznqQJzUY4

Local or National Regulatory Issues
Explore the regulatory, pricing, or market access challenges that could impact your brand in various markets. Discuss these challenges with your advisors to strategize overcoming hurdles and understand the logistics of entering new markets, whether mature or emerging.

For more questions you should be asking your advisors, check out our blog: https://www.impetusdigital.com/2020/02/03/top-10-most-important-advisor-questions/

Discover more insights and strategies for tackling challenges in Pharma and Life Sciences across our video series. Learn how Impetus Digital’s innovative platform and services can bolster your strategic objectives.

Stay connected for more updates and insights:

Visit our website: impetusdigital.com
Book a demo: meetwithimpetus.com/

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Helping Patients Become Active Participants in Their Own Care

Rishi Nayyar, Co-founder & CEO of PocketHealth, explores how releasing medical imaging records straight to patients can result in data moving more ethically, easily, and securely. He also shares his...

Virtual Speaker Program: A Customer Story

Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions.

Impact of COVID-19 on the Biopsychosocial Model of Health

Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and...

Leaders in Pharma: Fran Milnes

In this episode of Impetus Digital's Leaders in Pharma podcast, I sit down with Fran Milnes. She is currently the Head of Marketing and Commercial Excellence in Oncology at Novartis.

FREE eBook: The Complete Guide to Virtualizing In-person Meetings

Download our latest eBook for free to learn about the innovative ways clients have used our synchronous and asynchronous virtual tools to engage participants and virtualize their meetings and events.

Open-Data Platforms for Direct Engagement with Patients, Researchers, and Pharma

Indu Navar, CEO and Founder of EverythingALS, explores the roles of Artificial Intelligence, Machine Learning, and Brain Computer Interface in the search for a cure for ALS. She will also...

Moving Away from Hospital-Centered Care: Barriers & Opportunities

David Barthel, CEO of Health Logic Interactive Inc., discusses their lab-on-chip, point-of-care platform technology for CKD. He also explores the issues with the hospital-centered model of care, shares his tips...

MSL Digital Offices and HCP Community Boards: A Customer Story

Learn how our client is leveraging the Impetus InSite Platform® to host company-wide “digital offices” and community boards for MSLs and HCPs to connect one-on-one or one-to-many.

Breaking Down the Wall: Blockchain in Healthcare and Pharma

Ray Dogum, Senior Consultant and Blockchain Strategist at ConsenSys Health and Podcaster at Health Unchained, explores blockchain in Pharma and healthcare, including innovative use cases, current barriers, and how to...

Building Better Patient Advocates Through Authentic Partnerships

Sabrina Hanna, Founder & CIO of the Cancer Collaborative, discusses precision medicine, innovation in oncology, how to build better patient advocates, and the current gaps when it comes to patient-centricity...